☆ 4.6 Letter

Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies

JAMA ONCOLOGY (2021)

Get Full Text
Add to Collection

Journal

JAMA ONCOLOGY
Volume 7, Issue 11, Pages 1722-1723

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2021.4771

Keywords

-

Categories

Oncology

Funding

  1. National Institutes of Health (NIH) [P50-CA140158]
  2. NIH [K12-CA133250, K23HL155890, TL1-TR002735, KL2-TR002734]
  3. Alnylam Pharmaceuticals
  4. Akari Therapeutics
  5. Pfizer, Inc.
  6. American Heart Association-RobertWood Johnson Foundation Faculty Development Program Grant

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.